Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
174 participants
OBSERVATIONAL
2023-02-28
2028-02-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cognitive Behavioral Aggression Treatment
NCT01264900
Facing Adverse Childhood Experiences
NCT05122988
A Community Support Network Intervention in SOAR Project Intimate Partner Violence-Related Traumatic Brain Injury
NCT04890925
Longitudinal, Multi-Dimensional Assessment of Recovery and Added Benefit of a Behavioral Health Intervention for Children With Abusive Head Trauma
NCT03447899
Exploring the Psycho-traumatic Impact of a Violent Act Commited at the Bordeaux-Gradignan Penitentiary Center
NCT05026450
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Abusive Head Trauma (AHT)
Blood test
Proteomic analyses on serum
Accidental traumatic brain injury
Blood test
Proteomic analyses on serum
Cranioplasty
Blood test
Proteomic analyses on serum
Infant malaise without AHT
Blood test
Proteomic analyses on serum
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Blood test
Proteomic analyses on serum
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Medical consultation for malaise, seizure (without fever), loss of consciousness, traumatic bain injury, or cranioplasty
* Blood test during medical care
* Accepted informed consent
Exclusion Criteria
* For control groups : medical history of child abuse
* For AHT group : rare metabolic disease (Menkes, etc..)
2 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospices Civils de Lyon
OTHER
University Hospital, Geneva
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kim Wiskott
Dre Kim Wiskott
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Tony Fracasso, Prof.
Role: STUDY_DIRECTOR
University Hospital, Geneva
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ginhoux Thiphanie
Lyon, Rhône, France
Wiskott Kim
Geneva, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2021-01971
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.